GeneDx Holdings Corp. (WGSWW)
WGSWW Stock Price Chart
Explore GeneDx Holdings Corp. interactive price chart. Choose custom timeframes to analyze WGSWW price movements and trends.
WGSWW Company Profile
Discover essential business fundamentals and corporate details for GeneDx Holdings Corp. (WGSWW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
23 Jul 2021
Employees
1.00k
Website
https://www.genedx.comCEO
Katherine A. Stueland
Description
GeneDx Holdings Corp., through its various operational units, specializes in delivering genomics-driven diagnostic and informational solutions. Central to its services is Centrellis, an advanced health intelligence platform powered by artificial intelligence. This platform effectively merges digital technologies with AI capabilities, enabling researchers to process and interpret extensive clinical and genomic datasets to generate thorough health insights. The company provides genetic testing for diagnosis, a range of screening programs, and pertinent information, with a primary focus on pediatric conditions, uncommon diseases affecting both adults and children, and screening for inherited cancers. GeneDx Holdings Corp. was established in 2017 and its main offices are located in Stamford, Connecticut.
WGSWW Financial Timeline
Browse a chronological timeline of GeneDx Holdings Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Aug 2026
EPS estimate is -$0.19, while revenue estimate is $111.01m.
Earnings released on 4 May 2026
EPS came in at -$0.28 falling short of the estimated -$0.02 by -1.77k%, while revenue for the quarter reached $102.25m , missing expectations by -9.07%.
Earnings released on 23 Feb 2026
EPS came in at $0.14 surpassing the estimated $0.10 by +36.85%, while revenue for the quarter reached $121.00m , beating expectations by +0.56%.
Earnings released on 28 Oct 2025
EPS came in at -$0.27 falling short of the estimated $0.42 by -162.69%, while revenue for the quarter reached $116.74m , beating expectations by +11.58%.
Earnings released on 29 Jul 2025
EPS came in at $0.36 surpassing the estimated $0.12 by +213.73%, while revenue for the quarter reached $102.69m , beating expectations by +20.18%.
Earnings released on 30 Apr 2025
EPS came in at -$0.02 falling short of the estimated $0.06 by -139.24%, while revenue for the quarter reached $87.12m , beating expectations by +9.63%.
Earnings released on 31 Dec 2023
EPS came in at -$0.99 , while revenue for the quarter reached $57.42m .
WGSWW Stock Performance
Access detailed WGSWW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
